TREATMENT
Real-World Data on Encorafenib Plus Panitumumab in BRAF V600E Metastatic CRCA population-based multicenter study examined real-world outcomes of the targeted therapy combination encorafenib plus panitumumab in patients with BRAF V600E-mutated metastatic colorectal cancer. (Clinical Colorectal Cancer)